Company Overview and News

17
Diamondback and Carlyle Form JV to Develop Permian Assets

2018-09-12 zacks - 1
While the lack of takeaway capacity in the prolific Permian play could mar the region’s growth prospects in the near future, Diamondback Energy, Inc. (FANG - Free Report) seems to be rather unfrazzled by this dilemma. The Texas-based Permian pure-play has been strategically working to further boost its presence in the region. While many producers have been reducing their spending levels in Permian and shifting their focus to other shale plays, Diamondback does not intend to re-evaluate its strategies.
JNEEP EGN CG JONE FANG

66
E&P Bottom Of The Barrel Club #18-4: The Second Half Kickoff Gets Muffed

2018-09-04 seekingalpha - 1
The 18 remaining companies in the Bottom of the Barrel Club recently reported 2Q results that were largely underwhelming overall.
ECR CRC APC PIO LGCYP LGCYO CRK DVN EPE SCAZP PIONF AXAS XTO MCEP ACTPF AREX MHRC EGC RXNRP REXXQ JNEEP SNZYP AST SN JGPK TALO BRMR SRCI MAGH JONE EOG DNR REXX BBG CHK CVX SGY LGCY HPR BRY AEUA

306
Stocks To Watch: Time To Talk Valuation

2018-09-01 seekingalpha - 8
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
HIBB JWN DKS AVGO APRN PCB SODA AMC TMUS PDYPF AKCA JONE COUP SOLO REV MESA CZR LJPC VZ HEAR FCAU BRC MGM GCO FB ULTA IGT TM IRBT VCNX CTXR LB GMVHF MTCH DBX KS JNEEP AAPL USAK TSG ZAGG PRTY KSU DDS MRVL COOL HMC GBX TSCO DSKE MU DG WRK BYD LOW LRCX TXN CTRP TWX HA SKYW GNC RCL RH UAL PFCF AMZN TWTR CATO BKS VLKAY OSTK AAL BKE BBY GWRE MDLZ GME ON NSC NAV GOOGL QCOM HD XLNX CHDN CPB WDAY FND JBLU QSII WIMHY ALK ADBE MDXG GM GOGO CROX DAL CWH WIMHF F TECH PANW COST M SAVE WMH W S PEP URBN

11
Jones Energy, Inc. Announces Reverse Stock Split

2018-08-20 globenewswire
AUSTIN, Texas, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Jones Energy, Inc. (NYSE: JONE) (“Jones Energy” or “the Company”) today announced that its Board of Directors has approved a reverse stock split for the Company’s issued and outstanding Class A and Class B common stock of 1 for 20, effective after market close on Friday September 7, 2018. Jones Energy’s Class A common stock will begin trading on a split-adjusted basis upon market opening the following Monday, September 10, 2018 on the New York Stock Exchange (“NYSE”) under the same ticker symbol, JONE, but with a new CUSIP.
JNEEP DTK JONE

11
Jones Energy, Inc. Forgoes Convertible Preferred Stock Dividend and Grants an Inducement Award to New CEO

2018-08-14 globenewswire
AUSTIN, Texas, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Jones Energy, Inc. (NYSE: JONE) (“Jones Energy” or “the Company”) is announcing that it will forgo payment of its previously declared contingent dividend on its 8% Series A Perpetual Convertible Preferred Stock (the “Preferred Stock”). Also, per NYSE Rule 303A.08, Jones Energy is announcing the grant of a Restricted Stock Unit (“RSU”) award to Carl F.
JNEEP JONE

11
Jones Energy, Inc. Announces 2018 Second Quarter Financial and Operating Results

2018-08-06 globenewswire
AUSTIN, Texas, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Jones Energy, Inc. (NYSE:JONE) (“Jones Energy” or “the Company”) today announced financial and operating results for the second quarter ended June 30, 2018 as well as initial production guidance for the third quarter of 2018.
JNEEP JONE

11
U.S. E&P Unit to Support Marathon Oil's (MRO) Q2 Earnings

2018-07-30 zacks
Marathon Oil Corporation (MRO - Free Report) is set to report second-quarter 2018 financial results on Aug 1 after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a profit of 21 cents on revenues of $1,495 million. In the last reported quarter, the company delivered an impressive 20.00% positive earnings surprise on the back of higher crude price realizations and robust production growth at the U.
CNQ JNEEP MUR.WI MUR MRO JONE

13
What's in the Cards for Concho (CXO) This Earnings Season?

2018-07-30 zacks
Concho Resources Inc. (CXO - Free Report) , a more than $22-billion market cap energy company, is set to release second-quarter 2018 financial results after the closing bell on Aug 1. In the last reported quarter, the company delivered an impressive positive earnings surprise of 23.46% on the back of higher commodity price realizations and robust production growth. As far as earnings beat is concerned, the company surpassed estimates in each of the last four quarters, delivering an average positive surprise of 40.
CNQ JNEEP MUR.WI CXO MUR JONE

24
U.S. Shale: NAV Analysis Of Anadarko Basin E&Ps - 2018 Q1 Update

2018-07-29 seekingalpha - 4
This report updates with 2018 Q1 results my initial report on the U.S. shale Anadarko Basin E&Ps. For definitions of terms and explanations of methodology, please reference the initial report published on 5/10/2018 US Shale: NAV Analysis of Anadarko Basin E&Ps covering Newfield Exploration (NYSE:NFX), Jones Energy (NYSE:JONE) and Gastar Exploration (NYSE:GST).
GST-A GST-B JNEEP GST NFX JONE

13
Will Crude Transition Drive Encana's (ECA) Q2 Earnings?

2018-07-27 zacks - 2
Canadian oil and natural gas producer Encana Corporation (ECA - Free Report) is expected to release second-quarter 2018 results on Wednesday, Aug 1. The current Zacks Consensus Estimate for the quarter under review is a profit of 9 cents on revenues of $1,140 million.
ECA ECN RSG JNEEP MUR.WI MUR MRO ECA JONE

11
What's in Store for Williams Companies (WMB) in Q2 Earnings?

2018-07-27 zacks
The Williams Companies, Inc. (WMB - Free Report) is set to release second-quarter 2018 results on Aug 1 after the closing bell. The Zacks Consensus Estimate for second-quarter earnings is pegged at 16 cents on revenues of $2,000 million. In the last reported quarter, the Tulsa, OK-based company delivered a negative earnings surprise of 9.52%. The company’s earnings surprise history also displays a dismal record.
JNEEP WMB MUR.WI MUR JONE

12
BP Gears Up to Report Q2 Earnings: What's in the Cards?

2018-07-27 zacks
BP plc (BP - Free Report) is expected to report second-quarter 2018 earnings on Jul 31, before the opening bell.
JNEEP MUR.WI MUR NVR TRN JONE SAM EOG

11
Whiting (WLL) Set to Beat Q2 Earnings on Output, Oil Price

2018-07-27 zacks
We expect Whiting Petroleum Corporation (WLL - Free Report) to beat expectations when it reports second-quarter 2018 results on Tuesday, Jul 31, after market closes. The current Zacks Consensus Estimate for the quarter under review is a profit of 61 cents on revenues of $501.2 million.
EQT WLL JNEEP MUR.WI MUR MRO JONE

12
Jones Energy, Inc. Appoints New Chief Executive Officer and Announces Changes to the Board of Directors

2018-07-20 globenewswire
AUSTIN, Texas, July 20, 2018 (GLOBE NEWSWIRE) -- Jones Energy, Inc. (NYSE:JONE) (“Jones Energy” or “the Company”) today announced that its Board of Directors has hired Mr. Carl F. Giesler, Jr. as the Company’s new Chief Executive Officer effective July 23, 2018.
NOA JNEEP MS NOA JONE HRG

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...